Market Segmentation
- Defibrillators Product Outlook (Revenue, USD Million, 2018 - 2030)
- Implantable Cardioverter Defibrillators (ICD)
- S-ICD
- T-ICD
- Single Chamber
- Dual Chamber
- CRT-D
- External Defibrillators (ED)
- Manual ED
- Automated ED
- Wearable cardioverter defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- Defibrillators End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospital
- Pre-hospital
- Public Access Market
- Alternate Care Market
- Home Healthcare
- Defibrillators Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- North America Defibrillators Product Outlook
- Implantable Cardioverter Defibrillators (ICD)
- Single Chamber
- Dual Chamber
- CRT-D
- S-ICD
- T-ICD
- External Defibrillators (ED)
- Manual ED
- Automated ED
- Wearable cardioverter defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- North America Defibrillators End-use Outlook
- Hospital
- Pre-hospital
- Public Access market
- Alternate Care Market
- Home Healthcare
- U.S.
- U.S. Defibrillators Product Outlook
- Implantable Cardioverter Defibrillators (ICD)
- Single Chamber
- Dual Chamber
- CRT-D
- S-ICD
- T-ICD
- External Defibrillators (ED)
- Manual ED
- Automated ED
- Wearable cardioverter defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- U.S. Defibrillators End-use Outlook
- Hospital
- Pre-hospital
- Public Access market
- Alternate Care Market
- Home Healthcare
- U.S. Defibrillators Product Outlook
- Canada
- Canada Defibrillators Product Outlook
- Implantable Cardioverter Defibrillators (ICD)
- Single Chamber
- Dual Chamber
- CRT-D
- S-ICD
- T-ICD
- External Defibrillators (ED)
- Manual ED
- Automated ED
- Wearable cardioverter defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- Canada Defibrillators End-use Outlook
- Hospital
- Pre-hospital
- Public Access market
- Alternate Care Market
- Home Healthcare
- Canada Defibrillators Product Outlook
- North America Defibrillators Product Outlook
- Europe
- Europe Defibrillators Product Outlook
- Implantable Cardioverter Defibrillators (ICD)
- Single Chamber
- Dual Chamber
- CRT-D
- S-ICD
- T-ICD
- External Defibrillators (ED)
- Manual ED
- Automated ED
- Wearable cardioverter defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- Europe Defibrillators End-use Outlook
- Hospital
- Pre-hospital
- Public Access market
- Alternate Care Market
- Home Healthcare
- Germany
- Germany Defibrillators Product Outlook
- Implantable Cardioverter Defibrillators (ICD)
- Single Chamber
- Dual Chamber
- CRT-D
- S-ICD
- T-ICD
- External Defibrillators (ED)
- Manual ED
- Automated ED
- Wearable cardioverter defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- Germany Defibrillators End-use Outlook
- Hospital
- Pre-hospital
- Public Access market
- Alternate Care Market
- Home Healthcare
- Germany Defibrillators Product Outlook
- UK
- UK Defibrillators Product Outlook
- Implantable Cardioverter Defibrillators (ICD)
- Single Chamber
- Dual Chamber
- CRT-D
- S-ICD
- T-ICD
- External Defibrillators (ED)
- Manual ED
- Automated ED
- Wearable cardioverter defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- UK Defibrillators End-use Outlook
- Hospital
- Pre-hospital
- Public Access market
- Alternate Care Market
- Home Healthcare
- UK Defibrillators Product Outlook
- France
- France Defibrillators Product Outlook
- Implantable Cardioverter Defibrillators (ICD)
- Single Chamber
- Dual Chamber
- CRT-D
- S-ICD
- T-ICD
- External Defibrillators (ED)
- Manual ED
- Automated ED
- Wearable cardioverter defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- France Defibrillators End-use Outlook
- Hospital
- Pre-hospital
- Public Access market
- Alternate Care Market
- Home Healthcare
- France Defibrillators Product Outlook
- Italy
- Italy Defibrillators Product Outlook
- Implantable Cardioverter Defibrillators (ICD)
- Single Chamber
- Dual Chamber
- CRT-D
- S-ICD
- T-ICD
- External Defibrillators (ED)
- Manual ED
- Automated ED
- Wearable cardioverter defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- Italy Defibrillators End-use Outlook
- Hospital
- Pre-hospital
- Public Access market
- Alternate Care Market
- Home Healthcare
- Italy Defibrillators Product Outlook
- Spain
- Spain Defibrillators Product Outlook
- Implantable Cardioverter Defibrillators (ICD)
- Single Chamber
- Dual Chamber
- CRT-D
- S-ICD
- T-ICD
- External Defibrillators (ED)
- Manual ED
- Automated ED
- Wearable cardioverter defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- Spain Defibrillators End-use Outlook
- Hospital
- Pre-hospital
- Public Access market
- Alternate Care Market
- Home Healthcare
- Spain Defibrillators Product Outlook
- Denmark
- Denmark Defibrillators Product Outlook
- Implantable Cardioverter Defibrillators (ICD)
- Single Chamber
- Dual Chamber
- CRT-D
- S-ICD
- T-ICD
- External Defibrillators (ED)
- Manual ED
- Automated ED
- Wearable cardioverter defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- Denmark Defibrillators End-use Outlook
- Hospital
- Pre-hospital
- Public Access market
- Alternate Care Market
- Home Healthcare
- Denmark Defibrillators Product Outlook
- Sweden
- Sweden Defibrillators Product Outlook
- Implantable Cardioverter Defibrillators (ICD)
- Single Chamber
- Dual Chamber
- CRT-D
- S-ICD
- T-ICD
- External Defibrillators (ED)
- Manual ED
- Automated ED
- Wearable cardioverter defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- Sweden Defibrillators End-use Outlook
- Hospital
- Pre-hospital
- Public Access market
- Alternate Care Market
- Home Healthcare
- Sweden Defibrillators Product Outlook
- Norway
- Norway Defibrillators Product Outlook
- Implantable Cardioverter Defibrillators (ICD)
- Single Chamber
- Dual Chamber
- CRT-D
- S-ICD
- T-ICD
- External Defibrillators (ED)
- Manual ED
- Automated ED
- Wearable cardioverter defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- Norway Defibrillators End-use Outlook
- Hospital
- Pre-hospital
- Public Access market
- Alternate Care Market
- Home Healthcare
- Norway Defibrillators Product Outlook
- Europe Defibrillators Product Outlook
- Asia Pacific
- Asia Pacific Defibrillators Product Outlook
- Implantable Cardioverter Defibrillators (ICD)
- Single Chamber
- Dual Chamber
- CRT-D
- S-ICD
- T-ICD
- External Defibrillators (ED)
- Manual ED
- Automated ED
- Wearable cardioverter defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- Asia Pacific Defibrillators End-use Outlook
- Hospital
- Pre-hospital
- Public Access market
- Alternate Care Market
- Home Healthcare
- China
- China Defibrillators Product Outlook
- Implantable Cardioverter Defibrillators (ICD)
- Single Chamber
- Dual Chamber
- CRT-D
- S-ICD
- T-ICD
- External Defibrillators (ED)
- Manual ED
- Automated ED
- Wearable cardioverter defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- China Defibrillators End-use Outlook
- Hospital
- Pre-hospital
- Public Access market
- Alternate Care Market
- Home Healthcare
- China Defibrillators Product Outlook
- India
- India Defibrillators Product Outlook
- Implantable Cardioverter Defibrillators (ICD)
- Single Chamber
- Dual Chamber
- CRT-D
- S-ICD
- T-ICD
- External Defibrillators (ED)
- Manual ED
- Automated ED
- Wearable cardioverter defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- India Defibrillators End-use Outlook
- Hospital
- Pre-hospital
- Public Access market
- Alternate Care Market
- Home Healthcare
- India Defibrillators Product Outlook
- Japan
- Japan Defibrillators Product Outlook
- Implantable Cardioverter Defibrillators (ICD)
- Single Chamber
- Dual Chamber
- CRT-D
- S-ICD
- T-ICD
- External Defibrillators (ED)
- Manual ED
- Automated ED
- Wearable cardioverter defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- Japan Defibrillators End-use Outlook
- Hospital
- Pre-hospital
- Public Access market
- Alternate Care Market
- Home Healthcare
- Japan Defibrillators Product Outlook
- Australia
- Australia Defibrillators Product Outlook
- Implantable Cardioverter Defibrillators (ICD)
- Single Chamber
- Dual Chamber
- CRT-D
- S-ICD
- T-ICD
- External Defibrillators (ED)
- Manual ED
- Automated ED
- Wearable cardioverter defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- Australia Defibrillators End-use Outlook
- Hospital
- Pre-hospital
- Public Access market
- Alternate Care Market
- Home Healthcare
- Australia Defibrillators Product Outlook
- South Korea
- South Korea Defibrillators Product Outlook
- Implantable Cardioverter Defibrillators (ICD)
- Single Chamber
- Dual Chamber
- CRT-D
- S-ICD
- T-ICD
- External Defibrillators (ED)
- Manual ED
- Automated ED
- Wearable cardioverter defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- South Korea Defibrillators End-use Outlook
- Hospital
- Pre-hospital
- Public Access market
- Alternate Care Market
- Home Healthcare
- South Korea Defibrillators Product Outlook
- Thailand
- Thailand Defibrillators Product Outlook
- Implantable Cardioverter Defibrillators (ICD)
- Single Chamber
- Dual Chamber
- CRT-D
- S-ICD
- T-ICD
- External Defibrillators (ED)
- Manual ED
- Automated ED
- Wearable cardioverter defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- Thailand Defibrillators End-use Outlook
- Hospital
- Pre-hospital
- Public Access market
- Alternate Care Market
- Home Healthcare
- Thailand Defibrillators Product Outlook
- Asia Pacific Defibrillators Product Outlook
- Latin America
- Latin America Defibrillators Product Outlook
- Implantable Cardioverter Defibrillators (ICD)
- Single Chamber
- Dual Chamber
- CRT-D
- S-ICD
- T-ICD
- External Defibrillators (ED)
- Manual ED
- Automated ED
- Wearable cardioverter defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- Latin America Defibrillators End-use Outlook
- Hospital
- Pre-hospital
- Public Access market
- Alternate Care Market
- Home Healthcare
- Brazil
- Brazil Defibrillators Product Outlook
- Implantable Cardioverter Defibrillators (ICD)
- Single Chamber
- Dual Chamber
- CRT-D
- S-ICD
- T-ICD
- External Defibrillators (ED)
- Manual ED
- Automated ED
- Wearable cardioverter defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- Brazil Defibrillators End-use Outlook
- Hospital
- Pre-hospital
- Public Access market
- Alternate Care Market
- Home Healthcare
- Brazil Defibrillators Product Outlook
- Mexico
- Mexico Defibrillators Product Outlook
- Implantable Cardioverter Defibrillators (ICD)
- Single Chamber
- Dual Chamber
- CRT-D
- S-ICD
- T-ICD
- External Defibrillators (ED)
- Manual ED
- Automated ED
- Wearable cardioverter defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- Mexico Defibrillators End-use Outlook
- Hospital
- Pre-hospital
- Public Access market
- Alternate Care Market
- Home Healthcare
- Mexico Defibrillators Product Outlook
- Argentina
- Argentina Defibrillators Product Outlook
- Implantable Cardioverter Defibrillators (ICD)
- Single Chamber
- Dual Chamber
- CRT-D
- S-ICD
- T-ICD
- External Defibrillators (ED)
- Manual ED
- Automated ED
- Wearable cardioverter defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- Argentina Defibrillators End-use Outlook
- Hospital
- Pre-hospital
- Public Access market
- Alternate Care Market
- Home Healthcare
- Argentina Defibrillators Product Outlook
- Latin America Defibrillators Product Outlook
- MEA
- MEA Defibrillators Product Outlook
- Implantable Cardioverter Defibrillators (ICD)
- Single Chamber
- Dual Chamber
- CRT-D
- S-ICD
- T-ICD
- External Defibrillators (ED)
- Manual ED
- Automated ED
- Wearable cardioverter defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- MEA Defibrillators End-use Outlook
- Hospital
- Pre-hospital
- Public Access market
- Alternate Care Market
- Home Healthcare
- South Africa
- South Africa Defibrillators Product Outlook
- Implantable Cardioverter Defibrillators (ICD)
- Single Chamber
- Dual Chamber
- CRT-D
- S-ICD
- T-ICD
- External Defibrillators (ED)
- Manual ED
- Automated ED
- Wearable cardioverter defibrillators
- South Africa Defibrillators End-use Outlook
- Hospital
- Pre-hospital
- Public Access market
- Alternate Care Market
- Home Healthcare
- Implantable Cardioverter Defibrillators (ICD)
- South Africa Defibrillators Product Outlook
- Saudi Arabia
- Saudi Arabia Defibrillators Product Outlook
- Implantable Cardioverter Defibrillators (ICD)
- Single Chamber
- Dual Chamber
- CRT-D
- S-ICD
- T-ICD
- External Defibrillators (ED)
- Manual ED
- Automated ED
- Wearable cardioverter defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- Saudi Arabia Defibrillators End-use Outlook
- Hospital
- Pre-hospital
- Public Access market
- Alternate Care Market
- Home Healthcare
- Saudi Arabia Defibrillators Product Outlook
- UAE
- UAE Defibrillators Product Outlook
- Implantable Cardioverter Defibrillators (ICD)
- Single Chamber
- Dual Chamber
- CRT-D
- S-ICD
- T-ICD
- External Defibrillators (ED)
- Manual ED
- Automated ED
- Wearable cardioverter defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- UAE Defibrillators End-use Outlook
- Hospital
- Pre-hospital
- Public Access market
- Alternate Care Market
- Home Healthcare
- UAE Defibrillators Product Outlook
- Kuwait
- Kuwait Defibrillators Product Outlook
- Implantable Cardioverter Defibrillators (ICD)
- Single Chamber
- Dual Chamber
- CRT-D
- S-ICD
- T-ICD
- External Defibrillators (ED)
- Manual ED
- Automated ED
- Wearable cardioverter defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- Kuwait Defibrillators End-use Outlook
- Hospital
- Pre-hospital
- Public Access market
- Alternate Care Market
- Home Healthcare
- Kuwait Defibrillators Product Outlook
- MEA Defibrillators Product Outlook
- North America
Defibrillators Market Dynamics
Driver-Increasing Prevalence of Cardiovascular Diseases Coupled with Supportive Legislative Reforms
Despite developments in treatment and prevention, sudden cardiac deaths are a leading cause of mortality, accounting for nearly half of all deaths from cardiovascular ailments. Increased prevalence of cardiac disorders and associated risk factors are anticipated to boost demand for cardiac resynchronization therapy devices. Heart failure is one of the leading causes of death around the globe. According to the CDC, in 2020, around 523 million individuals globally were suffering from heart conditions, and around 19 million individuals died due to some form of CVD, which represents around 32% of all the deaths globally, with an increase of around 18.7% from 2010. Moreover, owing to the rising prevalence of sudden cardiac arrest, the demand for defibrillators is constantly rising. Cardiac arrests are typically severe or fatal, and the survival rates in many countries are extremely low, majorly high in out-of-hospital arrests. For instance, according to the Heart and Stroke Statistics 2022 by the American Heart Association, more than 356,000 out-of-hospital cardiac arrests occur in the U.S. every year, with around 90% of them leading to death.
Driver-Technological Advancements in Defibrillators
The introduction of technological innovations in defibrillators is expected to drive the market. AEDs have been upgraded with numerous new features, such as LCD screens, rechargeable batteries, voice prompts, and new types of shocks. As a result, vendors have been concentrating more on the development of innovative AEDs. In August 2021, Kestra Medical Technologies, Inc. announced that the company received premarket approval from the U.S. FDA for the ASSURE Wearable Cardioverter Defibrillator system. The company designed the ASSURE system with the available up-to-date technology. Similarly, in February 2023, Medtronic received CE mark approval for the Epsila EV MRI SureScan and Aurora EV-ICD MRI SureScan, an extravascular implantable defibrillator for the treatment of arrhythmia. The Aurora EV-ICD patients have anti-tachycardia pacing (ATP), defibrillation, and backup pacing therapies. Manufacturers in the market have developed new varieties of defibrillators with substantial advancements over known products. These new designs of defibrillators are battery-powered and pneumatic, which ensures increased patient safety and significantly reduced time requirements by eliminating cords and the need for pressurized air.
Restraint-Product Recall
In August 2022, Medtronic recalled its Cobalt and Crome ICDs from the U.S. owing to their potential to reduce shock energy. The recall was class I and covered more than 20,000 units of these ICDs. Around 41 devices were identified with problems in August 2022, and around 0.05% of those devices were distributed globally. In February 2021, Medtronic recalled multiple ICDs and CRT-Ds, including Evera, Viva, Claria, Visia, Brava, Amplia, and Compia. These products were distributed from 31 August 2012 to 9 May 2018. The products were recalled due to a rapid and unexpected decrease in battery life. Similarly, in June 2021, Boston Scientific Corporation recalled the INGENIO pacemakers and CRT-Ps, including INGENIO DR EL, VITALIO DR EL, and ADVANTIO DR EL. These products were manufactured from September 2011 to December 2018 and distributed from 1 November 2011 to 1 August 2020. Around 48,000 devices were recalled in the U.S. due to the high risk associated with transitioning to the safety mode of the devices. Hence, a rising number of product recalls is anticipated to negatively impact the adoption of defibrillators, restricting market growth over the projected period.
What Does This Report Include?
This section will provide insights into the contents included in this defibrillators market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.
Defibrillators market qualitative analysis
-
Industry overview
-
Industry trends
-
Market drivers and restraints
-
Market size
-
Growth prospects
-
Porter’s analysis
-
PESTEL analysis
-
Key market opportunities prioritized
-
Competitive landscape
-
Company overview
-
Financial performance
-
Product benchmarking
-
Latest strategic developments
-
Defibrillators market quantitative analysis
-
Market size, estimates, and forecast from 2018 to 2030
-
Market estimates and forecast for product segments up to 2030
-
Regional market size and forecast for product segments up to 2030
-
Market estimates and forecast for application segments up to 2030
-
Regional market size and forecast for application segments up to 2030
-
Company financial performance
We are committed towards customer satisfaction, and quality service.
"The quality of research they have done for us has been excellent."
